全文获取类型
收费全文 | 4792篇 |
免费 | 231篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 88篇 |
妇产科学 | 18篇 |
基础医学 | 449篇 |
口腔科学 | 78篇 |
临床医学 | 292篇 |
内科学 | 1365篇 |
皮肤病学 | 236篇 |
神经病学 | 252篇 |
特种医学 | 135篇 |
外科学 | 919篇 |
综合类 | 28篇 |
预防医学 | 117篇 |
眼科学 | 64篇 |
药学 | 309篇 |
中国医学 | 4篇 |
肿瘤学 | 638篇 |
出版年
2023年 | 25篇 |
2022年 | 68篇 |
2021年 | 99篇 |
2020年 | 51篇 |
2019年 | 75篇 |
2018年 | 65篇 |
2017年 | 56篇 |
2016年 | 81篇 |
2015年 | 93篇 |
2014年 | 86篇 |
2013年 | 117篇 |
2012年 | 215篇 |
2011年 | 206篇 |
2010年 | 115篇 |
2009年 | 118篇 |
2008年 | 185篇 |
2007年 | 164篇 |
2006年 | 187篇 |
2005年 | 190篇 |
2004年 | 205篇 |
2003年 | 205篇 |
2002年 | 203篇 |
2001年 | 186篇 |
2000年 | 211篇 |
1999年 | 158篇 |
1998年 | 75篇 |
1997年 | 63篇 |
1996年 | 50篇 |
1995年 | 56篇 |
1994年 | 60篇 |
1993年 | 43篇 |
1992年 | 102篇 |
1991年 | 109篇 |
1990年 | 95篇 |
1989年 | 110篇 |
1988年 | 99篇 |
1987年 | 85篇 |
1986年 | 113篇 |
1985年 | 87篇 |
1984年 | 51篇 |
1983年 | 58篇 |
1982年 | 31篇 |
1979年 | 39篇 |
1978年 | 22篇 |
1977年 | 44篇 |
1975年 | 27篇 |
1972年 | 29篇 |
1971年 | 30篇 |
1970年 | 32篇 |
1969年 | 21篇 |
排序方式: 共有5043条查询结果,搜索用时 15 毫秒
91.
92.
HBME‐1 and CD15 immunocytochemistry in the follicular variant of thyroid papillary carcinoma
下载免费PDF全文
![点击此处可从《Pathology international》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Makoto Ohta Tadakazu Ookoshi Hironobu Naiki Yoshiaki Imamura 《Pathology international》2015,65(3):119-125
Papillary carcinoma is the most common thyroid malignancy. As the cytological diagnosis of papillary carcinoma is not difficult in patients with the usual type of lesion, fine‐needle aspiration (FNA) cytology is an effective method for preoperative evaluation. However, this modality is often ineffective in identifying the follicular variant of papillary thyroid carcinoma (FVPTC) due to its similarity to other follicular lesions and the incompleteness of typical nuclear features. Therefore, we investigated the expression of immunocytochemical markers of papillary carcinoma in cytological specimens of FVPTC and evaluated their utilities. The immunoreactivity of HBME‐1 and CD15 was investigated using 50 imprint smear cytological specimens obtained from thyroid lesions, including 13 FVPTC. The sensitivity and specificity of HBME‐1 for FVPTC were 92% and 89%, respectively, while those of CD15 were 23% and 100%, respectively. In conclusion, HBME‐1 is a sensitive marker of papillary carcinoma, including both usual type and FVPTC, in cytological specimens. Therefore, using HBME‐1 immunocytochemistry in FNA cytology will lead to reduction of the incidence of false‐negative diagnoses of FVPTC. Although CD15 is apparently inferior in terms of sensitivity for FVPTC, its excellent specificity will support the definitive diagnosis of thyroid malignancies, including FVPTC, after screening with HBME‐1. 相似文献
93.
94.
Kohji Nagayama Katsutaro Morino Osamu Sekine Fumiyuki Nakagawa Atsushi Ishikado Hirotaka Iwasaki Takashi Okada Masashi Tawa Daisuke Sato Takeshi Imamura Yoshihiko Nishio Satoshi Ugi Atsunori Kashiwagi Tomio Okamura Hiroshi Maegawa 《Nutrients》2015,7(9):8112-8126
N-3 polyunsaturated fatty acids such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) have protective effects against atherosclerosis. Monocyte chemotactic protein (MCP)-1 is a major inflammatory mediator in the progression of atherosclerosis. However, little is known about the regulation of Mcp-1 by DHA and EPA in vessels and vascular smooth muscle cells (VSMCs). In this study, we compared the effect of DHA and EPA on the expression of Mcp-1 in rat arterial strips and rat VSMCs. DHA, but not EPA, suppressed Mcp-1 expression in arterial strips. Furthermore, DHA generated 4-hydroxy hexenal (4-HHE), an end product of n-3 polyunsaturated fatty acids (PUFAs), in arterial strips as measured by liquid chromatography-tandem mass spectrometry. In addition, 4-HHE treatment suppressed Mcp-1 expression in arterial strips, suggesting 4-HHE derived from DHA may be involved in the mechanism of this phenomenon. In contrast, Mcp-1 expression was stimulated by DHA, EPA and 4-HHE through p38 kinase and the Keap1-Nuclear factor erythroid-derived 2-like 2 (Nrf2) pathway in VSMCs. In conclusion, there is a dual effect of n-3 PUFAs on the regulation of Mcp-1 expression. Further study is necessary to elucidate the pathological role of this phenomenon. 相似文献
95.
Asaoka Kohei Watanabe Yuki Itoh Kazuhiro Hosono Naoko Hirota Tomoya Ikawa Masamichi Yamaguchi Tomohisa Hatta Satomi Imamura Yoshiaki Nishino Ichizo Yamauchi Takahiro Iwasaki Hiromichi 《Clinical rheumatology》2021,40(6):2477-2483
Clinical Rheumatology - Eosinophilic fasciitis (EF) is a rare connective tissue disease that causes inflammation and fibrosis of the fascia, inducing pain and motor dysfunction. Characteristic skin... 相似文献
96.
Shigeki Arii Junji Tanaka Kenichi Fujita Kazunobu Monden Masayuki Imamura 《Journal of hepato-biliary-pancreatic sciences》1994,1(3):263-266
A major problem in treating hepatocellular carcinoma (HCC) is intrahepatic recurrence after partial hepatectomy, despite the relatively early detection now possible due to recent developments in non-invasive diagnostic modalities. The present study evaluated the usefulness of preventive therapy for intrahepatic recurrence of HCC. In order to suppress intrahepatic recurrence in HCC patients at high risk of recurrence after tumor removal, we performed preventive transarterial chemotherapy in 23 such patients. Doxorubicin, at a dose of 0.5 mg/kg body weight, was administered, via a catheter inserted at the junction of the common hepatic artery and the gastroduodenal artery, every 2 weeks for the first 2 months, and every month thereafter for at least 1 year. The control group consisted of 30 patients with similar risk of recurrence who underwent partial hepatectomy during the same period without receiving transarterial preventive therapy. The 1-, 2-, 3-, and 5-year cumulative cancer-free survival rates in patients who received transarterial preventive chemotherapy after partial hepatectomy were 87.0%, 47.1%, 21.2%, and 21.2%, respectively, compared to 53.3%, 30.0%, 20.0%, and 13.3%, respectively, in the control group (P<0.05). The 1-, 2-, 3-, and 5-year cumulative overall survival rates were 95.7%, 81.2%, 58.4%, and 48.7%, respectively, in the preventive chemotherapy group, compared to 70.0%, 49.4%, 41.7%, and 19.5%, respectively, in the control group (P<0.05). Thus, the present study demonstrates the limited but significant effect of preventive transarterial chemotherapy for the intrahepatic recurrence of HCC after partial hepatectomy. 相似文献
97.
Furumoto K Arii S Mori A Furuyama H Gorrin Rivas MJ Nakao T Isobe N Murata T Takahashi C Noda M Imamura M 《Hepatology (Baltimore, Md.)》2001,33(1):189-195
The RECK (reversion-inducing-cysteine-rich protein with Kazal motifs) gene was initially isolated as a transformation suppressor gene. It encodes a membrane-anchored glycoprotein with multiple serine protease inhibitor-like domains. The RECK gene is expressed widely in normal organs but is undetectable in many tumor-derived cell lines. When artificially expressed in such cell lines, RECK suppresses their invasive and metastatic activities. Clinical implications of these findings, however, remained undefined because of the lack of studies using fresh human tumor samples. In the present study, we have addressed this issue by analyzing the levels of RECK gene expression in hepatocellular carcinoma (HCC). RECK mRNA was detectable by RNA blot hybridization in all the tumorous and contiguous nontumorous tissues obtained from 64 patients with HCC. In 26 cases, the RECK expression in tumorous tissues was higher than that in nontumorous tissues. The expression of RECK protein in these tissues could also be demonstrated by immunohistochemistry. Patients with high RECK mRNA expression in tumorous tissues tended to show better survival (P =.02), and such tumors had a tendency to be less invasive. Univariate and multivariate analysis revealed that the RECK mRNA expression is a novel and independent variable affecting overall survival (P =.01). These findings support the hypothesis that RECK has negative effects on the invasiveness of HCC cells and suggest the feasibility of RECK mRNA as a promising prognostic molecular marker for HCC. 相似文献
98.
Masaru Nakagawa Syogo Kimura Keiji Fujimoto Hirokatsu Atumi Jyunko Imura Yoshihiro Chikazawa Hidetsugu Imamura Hiroshi Okuyama Hideki Yamaya Toshihiro Fukushima Atsushi Nakagawa Mitsuhiro Asaka Hitoshi Yokoyama 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2008,12(6):509-513
Plasmapheresis for the treatment of hypertriglyceridemia has previously been performed in patients with sudden onset severe hypertriglyceridemia and acute pancreatitis; however, only a few reports of this procedure have been published. We report here on a case showing severe hypertriglyceridemia during asparaginase (Asp) treatment for acute lymphocytic leukemia (ALL), and give an overview of a lipid‐lowering apheresis therapy. To prevent the complication of pancreatitis due to hypertriglyceridemia, we performed plasma exchange (PE) three times using fresh frozen plasma. PE remarkably reduced both serum triglyceride and total cholesterol levels from 5430 mg/dL to 403 mg/dL and from 623 mg/dL to 204 mg/dL, respectively. The causes of severe hyperlipidemia in this patient were considered to include: the Asp treatment for ALL, and a genetic background with a heterozygote of familial lipoprotein lipase (LPL) defect syndrome, because the patient's plasma LPL level after intravenous heparin injection was low at 137 ng/mL. Hence, PE using fresh frozen plasma may be useful not only to remove lipoproteins, but also to supply defective factors, such as LPL, in similar cases. 相似文献
99.